Undervalued Small-Cap Stocks on NAS May 2024

May 27, 2024

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the NAS

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
TCON TRACON Pharma 1.49 14.18 851.81 154105 0 0.00 0.0
LYRA Lyra Therapeutics 0.33 2.00 514.44 8307029 21 0.00 0.0
CETX Cemtrex 0.36 2.19 507.64 4227934 0 0.00 0.0
PSNYW Polestar Automotive 0.12 0.67 468.75 78888 250 0.00 0.0
EMKR EMCORE 0.94 5.05 435.43 571927 8 0.00 0.0
ATXI Avenue Therapeutics 3.62 18.91 422.45 138500 0 0.00 0.0
AKTS Akoustis Technologies 0.21 1.00 385.44 29336896 19 0.00 0.0
PSNY Polestar Automotive 0.78 3.55 355.16 7848188 1646 0.00 0.0
CRNC Cerence 3.21 14.31 345.89 2101435 134 0.00 0.0
DMTK DermTech 0.39 1.64 320.32 1087381 14 0.00 0.0
All data provided as at market close May 23, 2024.

Company Details

TRACON Pharma

TCON:NAS

Close Price

1.49

Our Valuation

14.18

% Difference

851.81

Market Cap ($M)

0

P/E Ratio

0.0

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.

Access the stockcalc valuation


Lyra Therapeutics

LYRA:NAS

Close Price

0.33

Our Valuation

2.00

% Difference

514.44

Market Cap ($M)

21

P/E Ratio

0.0

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases.

Access the stockcalc valuation


Cemtrex

CETX:NAS

Close Price

0.36

Our Valuation

2.19

% Difference

507.64

Market Cap ($M)

0

P/E Ratio

0.0

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes the Security segment, Industrial Services segment and the Corporate segment. It generates maximum revenue from the Security segment. It geographically operates in USA, UK and India wherein maximum revenue is generated in USA.

Access the stockcalc valuation


Polestar Automotive

PSNYW:NAS

Close Price

0.12

Our Valuation

0.67

% Difference

468.75

Market Cap ($M)

250

P/E Ratio

0.0

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

EMCORE

EMKR:NAS

Close Price

0.94

Our Valuation

5.05

% Difference

435.43

Market Cap ($M)

8

P/E Ratio

0.0

EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.

Access the stockcalc valuation


Avenue Therapeutics

ATXI:NAS

Close Price

3.62

Our Valuation

18.91

% Difference

422.45

Market Cap ($M)

0

P/E Ratio

0.0

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

Access the stockcalc valuation


Akoustis Technologies

AKTS:NAS

Close Price

0.21

Our Valuation

1.00

% Difference

385.44

Market Cap ($M)

19

P/E Ratio

0.0

Akoustis Technologies Inc is an emerging commercial product company focused on developing, designing, and manufacturing innovative RF filter solutions for the wireless industry, including for products such as smartphones and tablets, network infrastructure equipment, WiFi Customer Premise Equipment and defense applications.

Access the stockcalc valuation


Polestar Automotive

PSNY:NAS

Close Price

0.78

Our Valuation

3.55

% Difference

355.16

Market Cap ($M)

1646

P/E Ratio

0.0

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Access the stockcalc valuation


Cerence

CRNC:NAS

Close Price

3.21

Our Valuation

14.31

% Difference

345.89

Market Cap ($M)

134

P/E Ratio

0.0

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services.

Access the stockcalc valuation


DermTech

DMTK:NAS

Close Price

0.39

Our Valuation

1.64

% Difference

320.32

Market Cap ($M)

14

P/E Ratio

0.0

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
TRACON Pharma and Lyra Therapeutics are the most undervalued Small-Cap stocks on the NAS. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-may-2024
TRACON Pharma $TCON and Lyra Therapeutics $LYRA are the most undervalued Small-Cap stocks on the #NAS. See the full list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-may-2024
TRACON Pharma and Lyra Therapeutics are the most undervalued Small-Cap stocks on the NAS. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-may-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.